Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant spatial » significant potential (Expand Search), significant negative (Expand Search)
spatial decrease » spatial release (Expand Search), substantial decrease (Expand Search), small decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant spatial » significant potential (Expand Search), significant negative (Expand Search)
spatial decrease » spatial release (Expand Search), substantial decrease (Expand Search), small decrease (Expand Search)
-
2261
-
2262
-
2263
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
2264
-
2265
-
2266
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
2267
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
2268
-
2269
-
2270
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
2271
-
2272
-
2273
-
2274
-
2275
-
2276
-
2277
-
2278
-
2279
Molecular docking showed that ABT-199 can fit into active site of ALK<sup>Mutant</sup>.
Published 2025Subjects: -
2280